LNLuciano Neder

Luciano Neder

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Luciano Neder has a total of 71 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Fetal Brain Tumor Harboring a Unique ROCK1::BRAF Fusion

    by Marllon Cindra Sant'ANa, Mariana Maschietto, Daniela Paz Leal, Ricardo de Santos de Oliveira, Mayara Ferreira Euzébio, Antonio Carlos dos Santos, Luciano Neder, Carlos Alberto Scrideli, Elvis Terci Valera

  • Open Access

    EGFL7 expression profile in IDH-wildtype glioblastomas is associated with poor patient outcome

    by Bruno Henrique Bressan da Costa, Aline Paixão Becker, Luciano Neder, Paola Gyuliane Gonçalves, Cristiane de Oliveira, Allan Dias Polverini, Carlos Afonso Clara, Gustavo Ramos Teixeira, Rui Manuel Reis, Lucas Tadeu Bidinotto

    Background: Despite the advances in glioblastoma (GBM) treatment, the average life span of patients is 14 months. Therefore, it is urgent to identity biomarkers of prognosis, treatment response, or development of novel treatment strategies. We previously described the association of high epidermal growth factor-like domain multiple 7 (EGFL7) expression and unfavorable outcome of pilocytic astrocytoma patients. The present study aims to analyze the prognostic potential of EGFL7 in GBM isocitrate dehydrogenase (IDH)-wildtype, using immunohistochemistry and in silico approaches.Methods: Spearman’s correlation analysis of The Cancer Genome Atlas RNA sequencing data was performed. The genes strongly correlated to EGFL7 expression were submitted to enrichment gene ontology and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis. Additionally, EGFL7 expression was associated with patient overall survival. The expression of EGFL7 was analyzed through immunohistochemistry in 74 GBM IDH-wildtype patients’ samples, and was associated with clinicopathological data and overall survival.Results: In silico analysis found 78 genes strongly correlated to EGFL7 expression. These genes were enriched in 40 biological processes and eight KEGG pathways, including angiogenesis/vasculogenesis, cell adhesion, and phosphoinositide 3-kinase–Akt, Notch, and Rap1 signaling pathways. The immunostaining showed high EGFL7 expression in 39 cases (52.7%). High immunolabelling was significantly associated with low Karnofsky Performance Status and poor overall survival. Cox analysis showed that GBMs IDH-wildtype with high EGFL7 expression presented a higher risk of death compared to low expression (hazard ratio, 1.645; 95% confidence interval, 1.021 to 2.650; p = .041).Conclusions: This study gives insights regarding the genes that are correlated with EGFL7, as well as biological processes and signaling pathways, which should be further investigated in order to elucidate their role in glioblastoma biology.


  • Adult giant cerebellar cavernous malformations: case report and review of the literature

    by Rodrigo Inácio Pongeluppi, Stephanie Naomi Funo de Souza, Luciano Neder, Luciano Furlanetti, Benedicto Oscar Colli, Matheus Fernando Manzolli Ballestero, Ricardo Santos de Oliveira

    Cavernous malformations are vascular malformations that can occur anywhere in the central nervous system (CNS). Giant cavernous malformations (GCM) are extremely rare in adults, especially in the posterior fossa. Herein, we described a 48-year-old male who presented with vertigo and postural instability for three months. Neuroimaging revealed a 131.15 cm3 heterogeneous midline upper cerebellar lesion. After a suboccipital craniotomy, a gross total resection (GTR) was accomplished. Histopathologic examination revealed a huge cavernous malformation. Only 27 GCM adult cases were reported in the English-based literature. Only two patients had cerebellar lesions and, to the best of our knowledge, this is the first case of cerebellar vermis GCM. We concluded that cerebellar GCM (CGCM) in adults are exceedingly rare and indolent lesions. These lesions can radiologically and clinically mimic neoplastic lesions that have to be considered in the differential diagnosis. GTR is the mainstay of treatment and, whenever possible, should be attempted.

  • Open Access

    Epidemiological features of meningiomas: a single Brazilian center’s experience with 993 cases

    by Benedicto Oscar Colli, Hélio Rubens Machado, Carlos Gilberto Carlotti Jr, João Alberto Assirati Jr, Ricardo Santos De Oliveira, Guilherme Gozzoli Podolsky Gondim, Antonio Carlos Dos Santos, Luciano Neder

    Background: Meningiomas are the most frequent primary central nervous system (CNS) tumors. Their geographical and ethnic characteristics need to be known, in order to enable rational treatment. Objective: To investigate clinical and epidemiological aspects in a series of patients with meningiomas. Methods: Retrospective analysis on the demographic profile, location and histopathology of 993 patients with meningiomas (768 operated and 225 not operated). Results: Meningiomas represented 43.8% of the primary CNS tumors; 6.8% were multiple tumors (14.7% with neurofibromatosis 2) and 0.6% were radiation-induced tumors. The mean ages were 53.0 and 63.9 years for operated and non-operated patients and the female/male ratios were 3.2:1 and 6.3:1. Diagnosis was made later among females. The peak incidences were in the 6th and 7th decades respectively for operated and non-operated patients. The incidence was low at early ages and higher among patients aged 70+ years. The meningiomas were intracranial in 96.5% and most were WHO grade I (88.9%) and transitional. In the spinal canal (3.5%), they occurred mainly in the dorsal region (all grade I; mostly transitional). The racial distribution was 1.0% in Asian-Brazilians, 87% in Caucasians and 12% in African-Brazilians. 83.4% and 51.6% of the patients were estimated to be recurrence-free at 10 and 20 years, and the mortality rate was 3%. Conclusions: Most of the demographic data were similar to what has been observed in other western centers. Differences were higher incidence of meningiomas, female and older predominance in non-operated patients, predominance in Caucasian, and higher association with neurofibromatosis 2.


  • Open Access

    Multidisciplinary approach in the clinical and laboratory investigation of a suspected case for anaplastic lymphoma associated with breast prosthesis

    by René Aloisio da Costa Vieira, Idam de Oliveira-Junior, Luciana da Fonseca Santos, Ana Paula Uema Watanabe, Wilson Eduardo Furlan Matos Alves, Luciano Neder

    Introduction: Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare subtype of CD30-positive and ALK- negative (anaplastic lymphoma kinase) T cell lymphoma, which can develop in the pericapsular fibrous tissue and the late seromas around breast implants. If BIA-ALCL is suspected, an adequate diagnostic flow is essential. Materials and methods: A flowchart of the procedures performed in the diagnostic investigation is discussed, associating a clinical case, and conducting a review on the topic. Results: In the assessment of late and recurrent periprosthetic seromas, prior communication from the surgeon and the pathologist is essential, aiming at the adequate collection and storage of the aspirated material. The material must be promptly fractionated for microbiological assessment by culture, immediate or transoperative cytologic assessment, immunophenotyping by flow cytometry (10 mL), direct cytopathological examination, and obtaining cell block material (50 mL). For flow cytometry, the material must be sent fresh, 70% alcohol or 10% buffered formalin can be added for the other procedures. If it is impossible to send the aspirated fluid to the laboratory in less than six hours, it can be temporarily stored in a refrigerator at 4°C. Immunophenotyping should be extensive, always assessing the expression of CD30 and ALK, regardless of cytological aspects. In cases of late and recurrent seromas in which BIA-ALCL is considered, even if initially discarded, it is suggested to perform capsulectomy with the removal of the prosthesis or careful clinical and laboratory monitoring. Conclusion: The diagnostic flowchart is essential, aiming at false-negative tests.

  • MicroRNA profile of pediatric pilocytic astrocytomas identifies two tumor-specific signatures when compared to non-neoplastic white matter

    by Luiz Guilherme Darrigo Júnior, Regia Caroline Peixoto Lira, Paola Fernanda Fedatto, David Santos Marco Antonio, Elvis Terci Valera, Simone Aguiar, José Andres Yunes, Silvia Regina Brandalise, Luciano Neder, Fabiano Pinto Saggioro, et al.

    Pilocytic astrocytoma (PA) is a low-grade neoplasm frequently found in childhood. PA is characterized by slow growth and a relatively good prognosis. Genetic mechanisms such as activation of MAPK, BRAF gene deregulation and neurofibromatosis type 1 (NF1) syndrome have been associated with PA development. Epigenetic signature and miRNA expression profile are providing new insights about different types of tumor, including PAs.


  • Open Access

    Paraneoplastic dermatomyositis associated with neuroendocrine tumor of an unknown primary site: A case report

    by Caroline Souza dos Anjos, Victor Domingos Lisita Rosa, Antônio Carlos Cavalcante Godoy, João Luiz Chicci Thomé, Liane Rapatoni, Fabiano Pinto Saggioro, Luciano Neder, Rodrigo de Oliveira, Harley Francisco de Oliveira, Fernanda Maris Peria


  • Hemispheric dysplasia and hemimegalencephaly: imaging definitions

    by Antonio Carlos Santos, Sara Escorsi-Rosset, Gustavo N. Simao, Vera C. Terra, Tonicarlo Velasco, Luciano Neder, Americo C. Sakamoto, Helio R. Machado

    Hemispheric dysplasia (HD) and hemimegalencephaly (HME) are both brain malformations with early clinical manifestation including developmental delay and intractable epilepsy. Sometimes the differentiation of these conditions is not simple. HME is an anomaly of cortical development caused by a combination of neural proliferation and cell migration dysfunction, showing lobar or hemispheric enlargement. On the other hand, HD shows no brain hypertrophy, and even brain atrophy, eventually. To compare both conditions, we reviewed clinical, MRI, and histopathology of 23 patients with developmental delay and refractory epilepsy treated with hemispheric surgery. Histologically, both groups presented polymicrogyria, focal cortical dysplasia, gray matter (GM) heterotopia, pachygyria, and agyria. The white matter (WM) showed different degrees of gliosis and myelin impairment. Even though with no specificity in histopathology, the degree of lesion was more impressive on HME. The combination of WM dysmyelination and hypertrophy leads to the so called hamartomatous appearing. Although not all HME showed brain enlargement and some HD might show no size changes or atrophy, the size of affected hemisphere and the hamartomatous appearance of the WM were the more relevant signs to differentiate both conditions. Brain MRI was the best diagnostic tolls because it allowed together high contrast resolution, whole brain coverage and spatial distribution analysis. HD and HMD showed brain asymmetry tendency, but in opposite directions. The size of affected hemisphere and the hamartomatous appearance of the WM were the more relevant signs to differentiate both conditions.


  • Mowat–Wilson syndrome: the first report of an association with central nervous system tumors

    by Elvis Terci Valera, Sabrine Teixeira Ferraz, María Sol Brassesco, Xiumei Zhen, Yiping Shen, Antonio Carlos dos Santos, Luciano Neder, Ricardo Santos Oliveira, Carlos Alberto Scrideli, Luiz Gonzaga Tone

    Mowat–Wilson syndrome (MWS) is a rare genetic condition where variable and multiple congenital anomalies including Hirschsprung's disease, intellectual disability, and prominent facial features are present. At molecular level, MWS is characterized by many different described mutations in the zinc finger E-box protein 2 (ZEB2) gene, ultimately leading to loss of gene function. This report is the first to describe the association of MWS with two different asynchronous malignant brain tumors (medulloblastoma and glioblastoma) occurring in a child.


  • RPS13and cell cycle signaling pathways in pituitary tumorigenesis

    by Clarissa Martins, Renata Camargo, Fabiano Saggioro, Luciano Neder, Helio Machado, Ayrton Moreira, Margaret Castro

    Introduction: Abnormalities in cell cycle pathways, such as CDKN1B (p27) underexpression, have been identified in the pathogenesis of pituitary adenomas, but their underlying mechanisms have not been elucidated. Ribosomal proteins have been recently related to pituitary tumorigenesis. In gastric cancer, RPS13 down-regulates p27 and promotes cell cycle progression; these mechanisms have not yet been explored in pituitary adenomas. Objective: To evaluate the relationship between RPS13 and CDKN1B, CDK2, CCNE1, MYC gene expression in pituitary tumorigenesis and its association to clinical findings. Methods: We studied four groups: non-functioning pituitary adenomas (NFPA, n=21), GH-secreting adenomas (n=18), ACTH-secreting adenomas (n=12) and normal pituitaries (n=07). Clinical and pathological data were collected. RNA was isolated by TRIzol method. Gene expression was assessed by qRT-PCR. Kruskal–Wallis test was used for continuous variables between groups and Fisher Exact test for categorical data. Results: Differential gene expression among the groups were observed in CDKN1B (P=0.03), CCNE1 (P=0.02) and MYC (P=0.002), but not RPS13 (P=0.1) and CDK2 (P=0.07). We observed CDKN1B underexpression in somatotrophinomas, CCNE1 overexpression in NFPA and MYC underexpression in NFPA. In corticotrophinomas, we found no association between gene expression and tumor size, remission or immunohistochemistry (IHC). In somatotrophinomas, no relationship was found between gene expression and tumor size, visual field, IGF-1 levels, basal and post-oGTT GH levels, IHC, post-surgery remission and disease control. Tumors with higher CDKN1B expression tended to achieve control with somatostatin agonist (P=0.08). In NFPA, higher CDK2 expression was associated to null cell subtype (P=0.03) with a tendency to correlate with tumor size (P=0.08). Higher CCNE1 expression was associated with remission (P=0.02). Conclusion: The p27-CDK2-CCNE1 pathway seems dysregulated in pituitary adenomas and may interact with other aberrant pathways, leading to an environment that may have putative role in pituitary tumorigenesis. Overexpression of RPS13, however, does not seem to be the underlying mechanism.